{"transactions":[{"id":702327,"issuer":{"id":23749,"kind":"organization","name":"Crestline Lending Solutions, LLC","symbol":"N/A"},"owners":[{"id":28302,"kind":"person","name":"Cochran John","position":1,"cik":"0001406773","reported_name":"Cochran John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Limited Liability Company Units","published_at":"2026-07-28T20:06:23.000Z","date":"2026-07-24","kind":"purchase","planned":false,"acquired":true,"shares":7643.117,"price":19.63,"value":150034.38671,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a purchase of securities from Crestline Lending Solutions, LLC (the \"Company\") in the form of a capital call. Under the terms of a subscription agreement between the reporting person and the Company, the reporting person is required to fund drawdowns to purchase the Company's units of limited liability interests up to the amount of their capital commitment with a minimum of ten business days' prior notice to the reporting person."}],"balance_after":7643.117,"source":{"system":"sec-edgar","filing":"0001628280-26-050148","document":"wk-form4_1785269180.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2035713/000162828026050148/wk-form4_1785269180.xml","form_type":"4"}},{"id":739603,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":28302,"kind":"person","name":"Cochran John","position":1,"cik":"0001406773","reported_name":"Cochran John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2026-06-12T15:42:39.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":50500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 10, 2027, subject to Mr. Cochran's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":50500,"derivative":{"exercise_price":3.99,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":50500},"source":{"system":"sec-edgar","filing":"0001214659-26-007396","document":"marketforms-73382.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406773/000121465926007396/marketforms-73382.xml","form_type":"4"}},{"id":1113181,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":28302,"kind":"person","name":"Cochran John","position":1,"cik":"0001406773","reported_name":"Cochran John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2025-06-12T17:58:00.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":42000,"price":3.41,"value":143220.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 20, 2025, subject to Mr. Cochran's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":42000,"derivative":{"exercise_price":3.41,"exercise_date":"2026-06-11","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001214659-25-009120","document":"marketforms-69480.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406773/000121465925009120/marketforms-69480.xml","form_type":"4"}},{"id":1471922,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":28302,"kind":"person","name":"Cochran John","position":1,"cik":"0001406773","reported_name":"Cochran John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2024-06-21T17:50:27.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 20, 2025, subject to Mr. Cochran's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":38000,"derivative":{"exercise_price":2.5,"exercise_date":"2025-06-20","expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001214659-24-011217","document":"marketforms-66324.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406773/000121465924011217/marketforms-66324.xml","form_type":"4"}},{"id":1845072,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":28302,"kind":"person","name":"Cochran John","position":1,"cik":"0001406773","reported_name":"Cochran John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2023-06-23T16:24:25.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 21, 2024, subject to Mr. Cochran's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":2.02,"exercise_date":"2024-06-21","expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001214659-23-008793","document":"marketforms-61959.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406773/000121465923008793/marketforms-61959.xml","form_type":"4"}},{"id":2221931,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":28302,"kind":"person","name":"Cochran John","position":1,"cik":"0001406773","reported_name":"Cochran John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2022-06-24T21:13:53.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 22, 2023, subject to Mr. Cochran's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":0.7132,"exercise_date":"2023-06-22","expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001214659-22-008294","document":"marketforms-56515.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406773/000121465922008294/marketforms-56515.xml","form_type":"4"}},{"id":2663430,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":28302,"kind":"person","name":"Cochran John","position":1,"cik":"0001406773","reported_name":"Cochran John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2021-06-17T22:51:27.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 15, 2022, subject to Mr. Cochran's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":20000,"derivative":{"exercise_price":4.04,"exercise_date":"2022-06-15","expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001214659-21-006719","document":"marketforms-53147.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406773/000121465921006719/marketforms-53147.xml","form_type":"4"}},{"id":2688772,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":28302,"kind":"person","name":"Cochran John","position":1,"cik":"0001406773","reported_name":"Cochran John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-01T20:11:59.000Z","date":"2021-05-10","kind":"gift","acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person gifted these shares of Common Stock to Event Facilities Fort Worth Inc. for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price is not applicable to acquisitions or dispositions resulting from bona fide gifts."}],"balance_after":99486,"source":{"system":"sec-edgar","filing":"0001214659-21-006162","document":"marketforms-52778.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406773/000121465921006162/marketforms-52778.xml","form_type":"4"}},{"id":2785984,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":28302,"kind":"person","name":"Cochran John","position":1,"cik":"0001406773","reported_name":"Cochran John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-17T00:20:18.000Z","date":"2021-03-12","kind":"other","acquired":true,"shares":19091,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distributions for no consideration of shares of common stock of the Issuer by the following entities, respectively (collectively, the \"Distributing Entities\"): MonoLine Rx, L.P., MonoLine Rx III, L.P., MonoSol Rx Genpar, L.P., and MRX Partners, LLC. The Reporting Person under this Form 4 possesses no voting or investment control over the securities held by the Distributing Entities."}],"balance_after":136986,"source":{"system":"sec-edgar","filing":"0001214659-21-003204","document":"marketforms-51914.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1406773/000121465921003204/marketforms-51914.xml","form_type":"4"}},{"id":2785983,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":28302,"kind":"person","name":"Cochran John","position":1,"cik":"0001406773","reported_name":"Cochran John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-17T00:20:18.000Z","date":"2021-03-12","kind":"other","acquired":true,"shares":11544,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distributions for no consideration of shares of common stock of the Issuer by the following entities, respectively (collectively, the \"Distributing Entities\"): MonoLine Rx, L.P., MonoLine Rx III, L.P., MonoSol Rx Genpar, L.P., and MRX Partners, LLC. The Reporting Person under this Form 4 possesses no voting or investment control over the securities held by the Distributing Entities."}],"balance_after":117895,"source":{"system":"sec-edgar","filing":"0001214659-21-003204","document":"marketforms-51914.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1406773/000121465921003204/marketforms-51914.xml","form_type":"4"}},{"id":2785982,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":28302,"kind":"person","name":"Cochran John","position":1,"cik":"0001406773","reported_name":"Cochran John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-17T00:20:18.000Z","date":"2021-03-12","kind":"other","acquired":true,"shares":8228,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distributions for no consideration of shares of common stock of the Issuer by the following entities, respectively (collectively, the \"Distributing Entities\"): MonoLine Rx, L.P., MonoLine Rx III, L.P., MonoSol Rx Genpar, L.P., and MRX Partners, LLC. The Reporting Person under this Form 4 possesses no voting or investment control over the securities held by the Distributing Entities."}],"balance_after":106351,"source":{"system":"sec-edgar","filing":"0001214659-21-003204","document":"marketforms-51914.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406773/000121465921003204/marketforms-51914.xml","form_type":"4"}},{"id":2785981,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":28302,"kind":"person","name":"Cochran John","position":1,"cik":"0001406773","reported_name":"Cochran John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-17T00:20:18.000Z","date":"2021-03-12","kind":"other","acquired":true,"shares":23038,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distributions for no consideration of shares of common stock of the Issuer by the following entities, respectively (collectively, the \"Distributing Entities\"): MonoLine Rx, L.P., MonoLine Rx III, L.P., MonoSol Rx Genpar, L.P., and MRX Partners, LLC. The Reporting Person under this Form 4 possesses no voting or investment control over the securities held by the Distributing Entities."}],"balance_after":98123,"source":{"system":"sec-edgar","filing":"0001214659-21-003204","document":"marketforms-51914.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406773/000121465921003204/marketforms-51914.xml","form_type":"4"}},{"id":3105341,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":28302,"kind":"person","name":"Cochran John","position":1,"cik":"0001406773","reported_name":"Cochran John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2020-06-18T20:05:19.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 16, 2021, subject to Mr. Cochran's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":14000,"derivative":{"exercise_price":5.3,"exercise_date":"2021-06-16","expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001214659-20-005755","document":"marketforms-49052.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406773/000121465920005755/marketforms-49052.xml","form_type":"4"}},{"id":3487574,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":28302,"kind":"person","name":"Cochran John","position":1,"cik":"0001406773","reported_name":"Cochran John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2019-06-17T20:47:39.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":13350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 13, 2020, subject to Mr. Cochran's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":13350,"derivative":{"exercise_price":4.38,"exercise_date":"2020-06-13","expiration_date":"2029-06-13","underlying":"Common Stock","underlying_shares":13350},"source":{"system":"sec-edgar","filing":"0001214659-19-004246","document":"marketforms-45221.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1406773/000121465919004246/marketforms-45221.xml","form_type":"4"}},{"id":3860775,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":28302,"kind":"person","name":"Cochran John","position":1,"cik":"0001406773","reported_name":"Cochran John","relationship":{"director":true}}],"security":"Stock Option (Right to Purchase)","published_at":"2018-07-27T01:11:09.000Z","date":"2018-07-24","kind":"grant","acquired":true,"shares":26700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 25% of the underlying shares vest on the first anniversary of the grant date, 25% of the underlying shares vest on the second anniversary of the grant date and the remaining 50% of the underlying shares vest on the third anniversary of the grant date, subject in each case to Mr. Cochran's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":26700,"derivative":{"exercise_price":15,"expiration_date":"2028-07-24","underlying":"Common Stock","underlying_shares":26700},"source":{"system":"sec-edgar","filing":"0001140361-18-033742","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1406773/000114036118033742/form4.xml","form_type":"4"}}]}